MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. (Q53441691)
Jump to navigation
Jump to search
scientific article published in February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. |
scientific article published in February 2009 |
Statements
MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres. (English)
Paula Martinez
Irene Siegl-Cachedenier
Juana M Flores
1 February 2009
8
1
2-17